Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma

J.J.C. Verhoeff, C. Lavini, M.E. van Linde, L.J.A. Stalpers, C.B.L.M. Majoie, J.C. Reijneveld, W.R. van Furth, D.J. Richel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1723-1727
JournalAnnals of Oncology
Volume21
Issue number8
DOIs
Publication statusPublished - 2010

Cite this

Verhoeff, J. J. C., Lavini, C., van Linde, M. E., Stalpers, L. J. A., Majoie, C. B. L. M., Reijneveld, J. C., ... Richel, D. J. (2010). Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma. Annals of Oncology, 21(8), 1723-1727. https://doi.org/10.1093/annonc/mdp591